País: Malta
Língua: inglês
Origem: Medicines Authority
PARACETAMOL
Accord Healthcare Ireland Ltd Euro House, Euro Business Park, Little Island Cork, T45 K857, Ireland
N02BE01
PARACETAMOL 10 mg/ml
SOLUTION FOR INFUSION
PARACETAMOL 10 mg/ml
POM
ANALGESICS
Withdrawn
2017-11-17
Page 1 of 6 PACKAGE LEAFLET: INFORMATION FOR THE USER PARACETAMOL 10 MG/ML SOLUTION FOR INFUSION PARACETAMOL For children and adults from 33 kg up READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET : 1. What Paracetamol is and what it is used for 2. What you need to know before you use Paracetamol 3. How to use Paracetamol 4. Possible side effects 5. How to store Paracetamol 6. Contents of the pack and other information 1. WHAT PARACETAMOL IS AND WHAT IT IS USED FOR This medicine is an analgesic (it relieves pain) and an antipyretic (it lowers fever). It is indicated for the short-term treatment of moderate pain, especially following surgery, and for the short-term treatment of fever. The 100 ml container is restricted to adults, adolescents and children weighing more than 33 kg 2. WHAT YOU NEED TO KNOW BEFORE YOU USE PARACETAMOL YOU SHOULD NOT BE GIVEN PARACETAMOL: - If you are allergic to paracetamol or any of the other ingredients of this medicine (listed in section 6) or to propacetamol hydrochloride (prodrug of paracetamol). - If you are allergic to propacetamol (another analgesic and a precursor of paracetamol) - If you suffer from a severe liver disease WARNINGS AND PRECAUTIONS Talk to your doctor, pharmacist or nurse before taking Paracetamol - If you suffer from a liver or kidney disease, or from alcohol abuse, - If you are taking other medicines containing paracetamol, - In cases of nutrition problems (malnutrition) or dehydration. It is recommended that a suitable analgesic oral treatment be used as soon as this route of administration is possible. Page 2 of 6 OTHER MEDICINES AND PARACETAMOL Tell your doctor or pharmacist if you a Leia o documento completo
Page 1 of 10 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Paracetamol 10 mg/ml solution for infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each container contains 1000 mg paracetamol. One ml contains 10 mg paracetamol Excipients with known effect: Sodium 0.02 mg/ml For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for infusion. The solution is clear , free from visible particles and colourless to slightly brownish. pH: 5.0-6.5 Theoretical Osm: 270-300 mOsm 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Paracetamol is indicated for the short-term treatment of moderate pain, especially following surgery, and for the short-term treatment of fever, when administration by intravenous route is clinically justified by an urgent need to treat pain or hyperthermia and/or when other routes of administration are not possible. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Intravenous use. The product is restricted to adults, adolescents and children weighing more than 33 kg. POSOLOGY : Dosing based on patient weight (please see the dosing table here below): PATIENT WEIGHT DOSE PER ADMINISTRATION VOLUME PER ADMINISTRATION MAXIMUM VOLUME OF PARACETAMOL (10 MG/ML) PER ADMINISTRATION BASED ON UPPER WEIGHT LIMITS OF GROUP (ML)** MAXIMUM DAILY DOSE * > 33 kg to ≤50 15 mg/kg 1.5 ml/kg 75 ml 60 mg/kg not Page 2 of 10 kg exceeding 3 g >50 kg with additional risk factors for hepatotoxicity 1 g 100 ml 100 ml 3 g >50 kg and no additional risk factors for hepatotoxicity 1 g 100 ml 100 ml 4 g * MAXIMUM DAILY DOSE: The maximum daily dose as presented in the table above is for patients that are not receiving other paracetamol containing products and should be adjusted accordingly taking such products into account. ** PATIENTS WEIGHING LESS WILL REQUIRE SMALLER VOLUMES. THE MINIMUM INTERVAL BETWEEN EACH ADMINISTRATION MUST BE AT LEAST 4 HOURS. THE MINIMUM INTERVAL BETWEEN EACH ADMINISTRATION IN PATIENTS WITH SEVERE RENAL INSUFFICIENCY MUST BE AT LEAST 6 HOURS. NO MORE THAN 4 DOSES T Leia o documento completo